Skip to main content

Table 1 Baseline characteristics of patients with mutated DNA in plasma (N = 77)

From: Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

 

All patients with mutated DNA in plasma

Parameter

N (%)

Age, years

 Median (range)

66 (35–79)

Gender

 Female

29 (38)

 Male

48 (62)

PS

 0–1

73 (95)

 2

4 (5)

Location of primary tumor

 Right/transverse colon

25 (32)

 Left colon

21 (27)

 Rectum

31 (40)

Primary disseminated disease

63 (81)

Number of metastatic sites

  ≤ 2

53 (69)

  > 2

24 (31)

Mutations in plasma DNA

 KRAS

64 (83)

 NRAS

3 (4)

 BRAF

10 (13)

  1. Abbreviations: N, number; PS, performance status. Some percentages do not add up to 100% due to rounding